CLINICAL_TRIALS
trial_result
· 2022-09-28
Clinical Trial Update: A Study of the Safety and Anesthetic Effect of AG-920 Topical Ophthalmic Solution [Phase 3]
Summary
Phase 3 trial evaluating the safety and anesthetic effect of AG-920 topical ophthalmic solution has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: American Genomics, LLC | Conditions: Anesthesia, Local | Phase 3 | Status: COMPLETED | Results posted: 2022-09-28